Accueil   Diary - News   All news CarThera’s SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors

CarThera’s SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors

Low Intensity Pulsed Ultrasound device can enhance delivery of
CAR-T therapies and penetration of checkpoint inhibitors into the
brain of preclinical glioma models; increasing probability of longlasting immunity

 

Article published in AACR’s Clinical Cancer Research journal describes results of preclinical work

 


Paris, France, June 9, 2021 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results in the testing of the combination of SonoCloud® technology with immunotherapies. This laboratory work was done in collaboration with Dr Amy Heimberger – a renowned expert in immunotherapies for glioblastoma (GBM) at the MD Anderson Cancer Center. The results were recently published online in the prestigious Clinical Cancer Research journal: ‘Opening of blood-brain barrier using low-intensity pulsed ultrasound (LIPU) enhances responses to immunotherapy in preclinical glioma models’.

 

Read the press release